uMed utilizes the ACCESS Research Platform to automate the clinical studies process by creating consented patient cohorts and integrating electronic health records with real-time clinical outcomes. This approach addresses the challenges of slow patient enrollment and limited access to diverse populations in clinical research, enabling faster and more representative studies.
Funding
$18.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical studies often face challenges related to slow patient enrollment, limited access to diverse patient populations, and difficulties in integrating electronic health records with real-time clinical outcomes. Traditional research methods can be costly and resource-intensive, hindering the ability to answer new research questions quickly.
Solution
uMed's ACCESS Research Platform accelerates clinical research by automating the creation of consented patient cohorts and integrating electronic health records with real-time clinical outcomes. The platform provides researchers with access to custom patient data and insights derived from the remote collection of electronic health records, clinical outcomes, patient-generated data, and biosamples. By leveraging a global network of healthcare institutions, uMed enables access to deeply characterized patient cohorts that match specific research requirements, facilitating faster and more representative studies. The platform aims to make research more accessible to a wider population, including previously untapped patient cohorts.
Target Audience
uMed's primary customers include life science companies, healthcare organizations, and clinical researchers seeking to accelerate clinical studies and generate insights to improve patient outcomes.
Features
- ACCESS Research Platform embedded across a global network of healthcare institutions
- Remote collection of electronic health records, clinical outcomes, patient-generated data, and biosamples
- Creation of deeply characterized, consented patient cohorts tailored to research requirements
- Master protocol embedded across a global healthcare network providing access to a large patient pool
- Real-time integrated clinical outcomes combining electronic health records, physician-reported outcomes, and patient-generated data
- REC approved protocol programs for credible clinical evidence